Vicarious Surgical (RBOT) Change in Accured Expenses (2020 - 2025)
Vicarious Surgical (RBOT) reported Change in Accured Expenses of -$2.2 million for Q3 2025, down 778.06% year-over-year from $319000.0 in Q3 2024, and up 13.55% on a QoQ basis from -$2.5 million in Q2 2025.
Vicarious Surgical (RBOT) has 6 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q3 2025.
- Quarterly Change in Accured Expenses fell 778.06% year-over-year to -$2.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$4.1 million (down 1530.16% YoY) and the FY2024 annual result came in at $309000.0, up 137.09% from the prior year.
- Change in Accured Expenses climbed to -$2.2 million in Q3 2025 per RBOT's latest filing, from -$2.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2021 and bottomed at -$2.5 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is $287000.0 (2025), against an average of $27000.0.
- Peak annual rise in Change in Accured Expenses reached 10227.55% in 2021, while the deepest fall reached 5779.1% in 2021.
- Tracing RBOT's Change in Accured Expenses over 5 years: stood at $2.8 million in 2021, then sank by 84.42% to $443000.0 in 2022, then tumbled by 165.69% to -$291000.0 in 2023, then soared by 192.78% to $270000.0 in 2024, then tumbled by 901.11% to -$2.2 million in 2025.
- Per Business Quant, the three latest RBOT Change in Accured Expenses figures stand at -$2.2 million (Q3 2025), -$2.5 million (Q2 2025), and $287000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.16 Mn |
| Sep 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 287,000.00 |
| Mar 31, 2025 | 287,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -291,000.00 |
| Dec 31, 2023 | -291,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Sep 30, 2023 | 330,000.00 |
| Jun 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | -1.98 Mn |
| Mar 31, 2023 | -1.98 Mn |
| Dec 31, 2022 | 443,000.00 |
| Dec 31, 2022 | 443,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Dec 31, 2021 | 2.84 Mn |
| Sep 30, 2021 | 68,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -552,974.00 |
| Jun 30, 2021 | -552,974.00 |
| Mar 31, 2021 | 1.34 Mn |
| Mar 31, 2021 | 1.34 Mn |
| Dec 31, 2020 | 27,538.00 |
| Dec 31, 2020 | 27,538.00 |
| Sep 30, 2020 | 12,367.00 |
| Sep 30, 2020 | 12,367.00 |
| Jun 30, 2020 | 9,737.00 |
| Jun 30, 2020 | 9,737.00 |